NR-28985金黄色葡萄球菌,WKZ-2(细菌）

NR-28985??Staphylococcus aureus, WKZ-2(Bacteria)|Staphylococcus aureus|WKZ-2|-60°C or colder|W van SchaikAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Staphylococcus aureus, Strain WKZ-2 (MRSA), NR-28985."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.Staphylococcus aureus (S. aureus), strain WKZ-2 was isolated in 2000 from a blood culture from a male infant with Pierre Robin syndrome who was undergoing treatment for a respiratory infection following intubation in The Netherlands.S. aureus, strain WKZ-2 is a methicillin-resistant S. aureus (MRSA) strain. S. aureus, strain WKZ-2 was deposited as MLST sequence type (ST) 30, positive for SCCmec (subtype IV) and for the genes encoding for the Ser-Asp (SD) dipeptide repeat proteins SdrC, SdrD, and Bbp and for the S. aureus Pathogenicity Island 2 (SaPI2), which contains the genes encoding for toxic shock syndrome toxin (TSST) and exfoliative toxin A (ETA). Strain WKZ-2 was the second staphylococcal isolate recovered from this patient. During the course of treatment for WKZ-1 (NR-28984), which included amoxicillin/clavulanic acid, amoxicillin, cefotaxime and flucloxacillin, two additional staphylococcal isolates were recovered: methicillin-resistant S. aureus (MRSA) strain WKZ-2 and S. epidermidis, isolate O7. Based on results from whole genome sequencing and pulsed-field gel electrophoresis, strain WKZ-2 was likely derived from strain WKZ-1 due to the transfer of SCCmec from S. epidermidis, isolate O7.1.Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.